Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a statewide program boost lung cancer screening and save lives?

NCT ID NCT07682597

Knowledge-focused Sponsor: Timothy Mullett Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This trial tests whether a program called QUILS™ can help two states—Mississippi and Nevada—improve how they screen people for lung cancer. The program focuses on making screening fair and high-quality, especially in underserved communities. Researchers will work with state health teams over four years to see if this approach increases screening rates and catches lung cancer earlier.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
QUILS™ state-based initiative (behavioral intervention)
What this could lead to
If successful, this approach could help states dramatically increase lung cancer screening rates and catch more cancers early, reducing deaths.
What could go wrong
This is an implementation study, not a direct treatment trial. Success depends on each state's ability to adopt the program, and results may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Jul 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Member of a state-based lung cancer screening implementation team in Mississippi or Nevada. * Leadership member of the Mississippi state team or Nevada state team * Active member of the Mississippi Lung Cancer Roundtable (MSLCRT) or Nevada Lung Cancer Coalition (NLCC) * Willing to participate in study-related assessments an implementation activities Exclusion Criteria: * None

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lung cancer screening are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Lung cancer screening

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    13 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Baptist Memorial Hospital

    RECRUITING

    New Albany, Mississippi, 38652, United States

  • Delta Health System

    RECRUITING

    Greenville, Mississippi, 38703, United States

  • Desert View Hospital

    RECRUITING

    Pahrump, Nevada, 89048, United States

  • Greenwood Leflore Hospital

    RECRUITING

    Greenwood, Mississippi, 38930, United States

  • Hattiesburg Clinic

    RECRUITING

    Hattiesburg, Mississippi, 39401, United States

  • Humboldt General Hospital

    RECRUITING

    Winnemucca, Nevada, 89445, United States

  • Memorial Hospital Gulfport

    RECRUITING

    Gulfport, Mississippi, 39501, United States

  • Mt. Grant General Hospital

    RECRUITING

    Hawthorne, Nevada, 89415, United States

  • North Mississippi Health Services

    RECRUITING

    Tupelo, Mississippi, 38801, United States

  • Renown Regional Medical Center

    RECRUITING

    Reno, Nevada, 89502, United States

  • Sierra Medical Center

    RECRUITING

    Reno, Nevada, 89511, United States

  • Sunrise Health

    RECRUITING

    Winchester, Nevada, 89109, United States

  • University of Mississippi Medical Center

    RECRUITING

    Jackson, Mississippi, 39216, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.